As PPAR-γ is believed to act as a tumor suppressor in lung cancer development, we hypothesized that PPAR-γ promoter would be hypermethylated in all tumor samples, and that frequency of hypermethylation would be greater in the more biologically aggressive cancer (metastatic OSA) than in primary lung tumors. This evidence concerns the gene PPARG and cancer.